Vioxx liens cut as lawyers request fee hike

Two Vioxx settlement news bits: Some 100 insurers have agreed to reduce the medical liens on Vioxx claimants, cutting the amount of their settlement cash that will be diverted to hospital bills; meanwhile, Vioxx plaintiff lawyers are asking a judge to nullify a cap on their contingency fees. Release | Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.